The FDA has approved Norditropin (somatropin [rDNA origin] injection, from Novo Nordisk) for the treatment of children with short stature born small for gestational age (SGA) with no catch-up ...

Norditropin FlexPro is expected to be available in the second quarter of 2010 in 5mg/1.5mL, 10mg/1.5mL and 15mg/1.5mL pens. For more information call (888) 668-6444 or visit www.norditropin-us.com.

Norditropin is expensive: The list price for the most commonly used pen is $1,535.70, and a typical month's supply costs more than $6,000, according to GoodRx, a website that helps patients get ...

GlobalData has predicted sales of Norditropin will be $960 million in 2030, with Sogroya contributing $294 million in that year. In April, Novo Nordisk filed for US and EU approval of Sogroya as a ...

FDA Approves Novo Nordisk's Norditropin for Treatment of Short Stature Associated with a Rare Genetic Disorder PRINCETON, N.J., June 1 -- Novo Nordisk today announced that Norditropin ...

Norditropin, the growth hormone prescribed most often, went into shortage in the fall of 2022. It's still scarce a year and a half later, despite assurances from Novo Nordisk, maker of the drug ...

Norditropin FlexPro receives FDA approval . Alaric DeArment. 3/3/2010. PRINCETON, N.J. The Food and Drug Administration has approved a Novo Nordisk treatment for growth hormone disorders, the ...

Meanwhile, sales of Norditropin, also developed by Novo Nordisk, are set to reach $960 in 2030, according to GlobalData. GlobalData is the parent company of Clinical Trials Arena.

Norditropin ® FlexPro ® is a pre-filled dial-a-dose pen containing Norditropin ®, a solution of human growth hormone. Norditropin ® [also called somatropin (rbe)], is used to treat: 1.

BOSTON (MarketWatch) -- Danish drugmaker Novo Nordisk A/S said early Friday that the FDA has approved its growth hormone therapy Norditropin for the treatment of short stature in children with ...

Novo Nordisk's  Norditropin Approved for Treatment of Children with Short Stature Associated with Turner Syndrome PRINCETON, N.J., Sept. 21 -- Novo Nordisk today announced that Norditropin(R) ...